The Asia Pacific Probiotics Dietary Supplements Market is expected to witness market growth of 9.1% CAGR during the forecast period (2021-2027).
Probiotics can be defined as the live microorganisms that, if taken in the suitable amount can offer many health benefits. In addition, many researches have shown that the balance or imbalance of bacteria in the digestive system is directly impacted by overall health and disease. Additionally, probiotics are capable of facilitating a healthy balance of gut bacteria and provide many health advantages. Moreover, factors like stress, age, and poor diets can lead to digestive problems, bloating, and decreased resistance to infection.
The APAC region is expected to witness a massive demand for probiotics dietary supplements due to the growing demand for the product from the nations like China and India, which is expected to fuel the growth of the regional market. Companies like Yakult are constantly upgrading their product offerings and rolling out new products in the regional market. Moreover, some of the growth catalysts for the regional probiotics dietary supplements market are fast-paced urbanization, and a drastic rise in the population of some countries. Therefore, these aspects are anticipated to create new growth avenues for industry players operating in the regional probiotics dietary supplements market during the forecasting period.
The China market dominated the Asia Pacific Probiotics Dietary Supplements Market by Country in 2020, and is expected to continue to be a dominant market till 2027; thereby, achieving a market value of $746.8 million by 2027. The Japan market is anticipated to grow at a CAGR of 10.1% during (2021 - 2027). Additionally, The India market is expected to experience a CAGR of 10.1% during (2021 - 2027).
Based on Form, the Probiotics Dietary Supplements market is segmented into Capsules, Chewables & Gummies, Powders, Tablets & Softgels, and Others. Based on End User, the market is segmented into Adults, Geriatric, Children, and Infants. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Koninklijke DSM N.V., DuPont de Nemours, Inc., Chr. Hansen holding A/S, Archer Daniels Midland Company, Probi AB, BioGaia AB, Vitakem Nutraceutical, Inc., and ProbioFerm.
Scope of the Study
Market Segments Covered in the Report:
By Form
- Capsules
- Chewables & Gummies
- Powders
- Tablets & Softgels
- and Others
By End User
- Adults
- Geriatric
- Children
- Infants
By Country
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
Key Market Players
List of Companies Profiled in the Report:
- Koninklijke DSM N.V.
- DuPont de Nemours, Inc.
- Chr. Hansen holding A/S
- Archer Daniels Midland Company
- Probi AB
- BioGaia AB
- Vitakem Nutraceutical, Inc.
- ProbioFerm
Unique Offerings from the Publisher
- Exhaustive coverage
- The highest number of market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Companies Mentioned
- Koninklijke DSM N.V.
- DuPont de Nemours, Inc.
- Chr. Hansen holding A/S
- Archer Daniels Midland Company
- Probi AB
- BioGaia AB
- Vitakem Nutraceutical, Inc.
- ProbioFerm
Methodology
LOADING...
